- GlobeNewswire•5 days ago
AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS)
Paris, 20 March 2017, 8am AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig`s disease Primary ...
- Barrons.com•7 days ago
Actively managed funds will prove their worth when the market corrects, correlations drop, rates rise, et cetera. About $586 billion has fled actively managed funds since 2015, while $1 trillion has poured into passively managed ones, according to Morningstar. Half of the asset managers surveyed by Cerulli Associates last year said they planned to lower fees.
- PR Newswire•16 days ago
NEW YORK, March 9, 2017 /PRNewswire/ -- AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") (NYSE: AB) today announced that preliminary assets under management ...
AB : Summary for AllianceBernstein Holding L.P. - Yahoo Finance
AllianceBernstein Holding L.P. (AB)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||21.60 x 500|
|Ask||22.80 x 800|
|Day's Range||21.60 - 21.80|
|52 Week Range||20.75 - 25.13|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||9.72|
|Dividend & Yield||2.68 (12.38%)|
|1y Target Est||N/A|